71 InagiR.KumagaiT.FujitaT.NangakuM
A helmet-mounted device measures helmet acceleration, not the brain, may be triggered off by cobbles, and can never be diagnostic
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
JAMA , 325(14), 1416-1425
The National Library of Medicine offers helpful background on how peptides function in the body